William Blair Reiterates “Outperform” Rating for Stevanato Group (NYSE:STVN)

Stevanato Group (NYSE:STVN)‘s stock had its “outperform” rating reissued by analysts at William Blair in a research report issued on Friday,RTT News reports. William Blair also issued estimates for Stevanato Group’s Q1 2026 earnings at $0.13 EPS, Q2 2026 earnings at $0.15 EPS, Q3 2026 earnings at $0.17 EPS and Q4 2026 earnings at $0.23 EPS.

Several other equities analysts also recently issued reports on STVN. UBS Group decreased their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday. Wolfe Research initiated coverage on Stevanato Group in a research report on Friday, December 13th. They set an “outperform” rating and a $28.00 price target on the stock. Bank of America increased their price objective on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Finally, Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of €27.75 ($30.16).

Stevanato Group Stock Up 4.9 %

Stevanato Group stock opened at €21.72 ($23.61) on Friday. The stock’s fifty day moving average is €21.38 and its two-hundred day moving average is €20.54. The stock has a market cap of $6.58 billion, a PE ratio of 46.21, a P/E/G ratio of 7.18 and a beta of 0.60. Stevanato Group has a 1-year low of €16.56 ($18.00) and a 1-year high of €33.49 ($36.40). The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21.

Stevanato Group (NYSE:STVN) last posted its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, hitting the consensus estimate of €0.20 ($0.22). The firm had revenue of €352.68 million during the quarter, compared to analysts’ expectations of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. On average, sell-side analysts expect that Stevanato Group will post 0.5 EPS for the current fiscal year.

Institutional Trading of Stevanato Group

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Van Berkom & Associates Inc. purchased a new stake in shares of Stevanato Group in the fourth quarter valued at approximately $39,000. Johnson Financial Group Inc. acquired a new position in shares of Stevanato Group during the 4th quarter worth $41,000. Wells Fargo & Company MN grew its stake in shares of Stevanato Group by 680.3% during the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock worth $71,000 after purchasing an additional 2,830 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of Stevanato Group by 1,457.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock valued at $123,000 after purchasing an additional 5,291 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock worth $162,000 after buying an additional 4,965 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.